Results: MSYS

Search articles by EPIC code
EPIC MSYS
views

Microsaic Systems – trading “remains in line” & partnership phase 2 “completed successfully”, so why the share price fall?

An intra-day (11:20am) “Bioprocessing partnership update & trading update” from mass spectrometry instruments developer Microsaic Systems (MSYS). This firstly “confirms that trading in 2018 remains in line with the board's expectations” and then that phase two of the partnership “with a global partner in bioprocessing… has now been completed successfully, with a clear addressable market identified and positive feedback received from potential customers”. So why a 25% share price fall, towards 1p?...

Page 2 of 3 (27 articles)
Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Complete Coverage

Recent Comments